CAS 205393-21-1: Bortezomib intermediates II
Description:Bortezomib intermediates II, with the CAS number 205393-21-1, is a chemical compound that serves as an intermediate in the synthesis of the proteasome inhibitor bortezomib, which is used in the treatment of multiple myeloma and certain types of lymphoma. This compound typically exhibits characteristics common to organic intermediates, such as being a solid at room temperature, with potential solubility in organic solvents. Its molecular structure includes functional groups that facilitate further chemical reactions, making it a crucial step in the synthetic pathway of bortezomib. The compound may possess specific reactivity patterns, including the ability to undergo nucleophilic substitutions or coupling reactions, which are essential for the formation of the final therapeutic agent. Safety data sheets would indicate handling precautions, as intermediates can often be hazardous. Overall, Bortezomib intermediates II plays a vital role in pharmaceutical chemistry, contributing to the development of effective cancer treatments.
- Synonyms:
- N-[(1S)-1-benzyl-2-({(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]
- (alphaS)-alpha-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide hydrochloride
- Bortezomib Intermediate II

Benzenepropanamide, α-amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-, hydrochloride (1:1), (αS)-
Ref: IN-DA002A28
1g | 297.00 € | ||
5g | To inquire | ||
100mg | 103.00 € | ||
250mg | 171.00 € |

Ref: 4Z-B-4667
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide Hydrochloride (Bortezomib Intermediate II)
Controlled ProductRef: 86-MM3368.04-0025
25mg | 901.00 € |

(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
Controlled ProductRef: TR-A609965
100mg | 1,568.00 € |

(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]ben zenepropanamideHydrochloride
Ref: 3D-FA151451
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |